Plain-English translation of NCT06934798 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
After heart surgery, some patients develop a serious condition called vasoplegic syndrome, where blood pressure drops dangerously despite adequate fluid given through an IV. This trial compares vasopressin to norepinephrine, two medications that work differently to raise blood pressure. Researchers want to understand which medication works better at improving the heart's function and blood flow in this specific situation.
Vasoplegic syndrome after heart surgery is life-threatening and doesn't respond well to standard treatments. Although norepinephrine is commonly used, this medication may have unwanted side effects. Vasopressin works through a different mechanism in the body and might be equally or more effective with fewer risks — but this needs to be tested directly.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either vasopressin or norepinephrine through an IV line that's adjusted gradually every 10 minutes until your blood pressure reaches a safe target. The medication assignment is blinded, meaning neither you nor your medical team will know which one you received. Your doctors will collect heart function measurements and blood tests at the start and after your blood pressure stabilizes, which typically takes less than an hour.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Brazil